Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CDGSH iron-sulfur domain-containing protein 2 (CISD2) is a membrane-associated member of the NEET protein family characterized by a conserved CDGSH motif that binds a [2Fe-2S] iron-sulfur cluster. CISD2 is located predominantly at the endoplasmic reticulum and mitochondria-associated membranes, where it regulates autophagy, apoptosis, and iron/ROS balance. Its biological roles make it relevant to multiple disease processes, including metabolic disorders, cancer, neurodegenerative diseases, and cardiovascular disease. CISD2 functions by maintaining mitochondrial integrity, antagonizing BECN1-mediated autophagy, and controlling mitochondrial signaling related to cell death and survival. Dysfunction or altered expression of CISD2 has been implicated in aging, neurodegeneration, and susceptibility to metabolic syndromes.
Drugs (or research compounds) targeting CISD2 are postulated to modulate mitochondrial iron-sulfur cluster transfer, regulate ROS, impact apoptosis, or modulate autophagy
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CDGSH iron-sulfur domain-containing protein 2 (CISD2).